Biographical Sketches of Committee Members and Staff
Georges C. Benjamin, M.D., (Committee Chair) is a well-known health policy leader, practitioner, and administrator. He currently serves as the executive director of the American Public Health Association (APHA), the nation’s oldest and largest organization of public health professionals. He is also a former secretary of health for the state of Maryland. Dr. Benjamin is a graduate of the Illinois Institute of Technology and the University of Illinois College of Medicine. He is board certified in internal medicine, a master of the American College of Physicians, a fellow of the National Academy of Public Administration, a fellow emeritus of the American College of Emergency Physicians, and a member of the National Academy of Medicine. At APHA he serves as the publisher for the American Journal of Public Health, The Nation’s Health newspaper, and APHA Press, the association’s book company. He serves on several nonprofit boards, such as Research!America, the Truth Foundation, the Environmental Defense Fund, Ceres, and the Reagan-Udall Foundation. He is also a former member of the National Infrastructure Advisory Council, a council that advises the president on how to best assure the security of the nation’s critical infrastructure.
Ana Abraído-Lanza, Ph.D., is vice dean of the School of Global Public Health and professor in the Department of Social and Behavioral Sciences at New York University (NYU). Prior to joining NYU, she was professor of sociomedical sciences at the Mailman School of Public Health of Colum-
bia University. She received her Ph.D. in psychology from The Graduate School at the City University of New York. Her research expertise includes the cultural, psychological, social, and structural factors that affect health, psychological well-being, mortality among Latinos, and the health of immigrant Latinos. She has served as a committee or board member on the Hispanic-Serving Health Professions Schools, the Community Task Force on Preventive Services of the Centers for Disease Control and Prevention (from 2006–2011), and several National Institutes of Health review groups among others. Dr. Abraído-Lanza’s honors and awards include being selected as a Columbia University Provost Leadership Fellow, as well as receiving the Teaching Excellence Award from the Mailman School of Public Health of Columbia University, a Dalmas A. Taylor Distinguished Contributions Award from the Minority Fellowship Program of the American Psychological Association, and the Student Assembly Public Health Mentoring Award from the American Public Health Association.
Michele Barry, M.D., FACP, FASTMH, is the Drs. Ben and A. Jess Shenson Professor of Medicine and Tropical Diseases at Stanford University, where she is the director of the Center for Innovation in Global Health and senior associate dean for Global Health. She is past president of the American Society of Tropical Medicine and Hygiene (ASTMH), where she led an educational initiative in tropical medicine and travelers’ health, which culminated in diploma courses in tropical medicine both in the United States and overseas, as well as a U.S. certification exam. Dr. Barry is an elected member of the National Academy of Medicine and an elected member of The American Academy of Arts and Sciences. She has been selected for Best Doctors in America and currently sits on the National Academies’ Board on Global Health. She is chair of the board of directors for the Consortium of Universities for Global Health and is a recipient of the Ben Kean Medal given every 3 years by the ASTMH to the outstanding tropical disease educator in the United States. She is a recipient of the Elizabeth Blackwell Award for mentoring women in the United States toward careers in medicine, and is the founder of the Gates-funded WomenLift program, a global women’s leadership program in the private and public health sectors. She has written on the impact of COVID-19 on female academics, among other areas in tropical diseases, and global and refugee health.
Ietza Bojorquez, M.D., MSc, Ph.D., is a professor-researcher at the Department of Population Studies, El Colegio de la Frontera Norte. From 2007–2010 she was the director of research at Mexico’s Directorate of Epidemiology, Ministry of Health, where she was in charge of the surveillance system for the H1N1 pandemic of 2009. She conducts research from a social epidemiology/social determinants of health perspective. Her research
focuses on mental health, migrant health, and the inclusion of migrants in health policies. Since 2018, she has been responsible for the Surveys on Migration in Mexico’s Borders, an interinstitutional effort to track migration flows in Northern and Southern Mexico. Her recent research projects address the health of Mexican migrants in the Mexico–U.S. migration corridor, as well as non-Mexican in-transit migrants and asylum seekers in Mexico. She has been part of research teams studying the “migrant caravans” in the Mexico–U.S. border. She is working on a project on the health-related impact of the COVID-19 pandemic on migrants in Mexico, which is funded by Mexico’s Ministry of Health through an agreement with the U.S. Centers for Disease Control and Prevention. She is a member of the board of the Latin America node, Lancet Commission on Migration and Health. She provided uncompensated expert public health evidence for the American Civil Liberties Union (ACLU) for litigation against the detention of migrants during the COVID-19 pandemic, which has been resolved, and has signed an ACLU declaration opposing the use of Title 42 to return asylum seekers at the U.S. border. She is part of Mexico’s National System of Researchers. She holds an M.D., an MSc in Public Health, and a Ph.D. in Epidemiology.
J. Bradley Dickerson, Ph.D., leads the Global Chemical and Biological Security (GCBS) group at Sandia National Laboratories (SNL). The GCBS group also works with the Centers for Disease Control and Prevention’s (CDC’s) Center for Surveillance, Epidemiology, and Laboratory Services on laboratory biorisk management through an interagency agreement between the CDC and SNL. Dr. Dickerson has held numerous leadership positions within the U.S. government. Prior to joining SNL, he served as the principal scientific officer in the Department of Justice’s National Security Division, working for the Committee on Foreign Investment in the United States. Prior to that, Dr. Dickerson served as the senior biodefense advisor and the director of chemical security policy at the Department of Homeland Security (DHS). At DHS he was responsible for the development and implementation of policies associated with chemical and biological defense, pandemic preparedness, and infectious disease–related border and transportation issues. Dr. Dickerson also led the policy and strategy component of the Office of Public Health Preparedness and Response at the CDC. He worked in the U.S. Senate as Senator Bob Corker’s foreign relations legislative assistant. Prior to government service, Dr. Dickerson was a researcher at St. Jude Children’s Research Hospital and a pharmaceutical chemist at Schering-Plough Health Care Products. Dr. Dickerson holds degrees in chemistry (B.S.), biomedical engineering (M.S.), and biochemistry (Ph.D.). He is a member of the Council on Foreign Relations.
Lawrence Gostin is University Professor, Georgetown University’s highest academic rank, and founding O’Neill Chair in Global Health Law. He directs the World Health Organization Center on National and Global Health Law. Professor Gostin served on two global commissions on the Ebola epidemic, and was senior advisor to the United Nations secretary general’s post-Ebola Commission. He served on the drafting committee for the G-7 Summit on global health security. A member of the National Academy of Medicine, he also serves on the National Academies’ Global Health Board. The National Academy and American Public Health Association awarded him their Distinguished Achievement Award. He’s a fellow of the Royal Society of Public Health and faculty of public health (UK). President Obama appointed Gostin to the President’s National Cancer Advisory Board. The National Consumer Council (UK) bestowed the Rosemary Delbridge Memorial Award for the person “who has most influenced Parliament and government to act for the welfare of society.”
Moon Kim, M.D., M.P.H., is a medical epidemiologist in charge of the Hospital Outbreak and Biothreat Response Unit of the Los Angeles County Department of Public Health’s (CDPH) Acute Communicable Disease Control (ACDC) Program and is responsible for investigating hospital outbreaks, emerging diseases (e.g., viral hemorrhagic fevers), and suspected cases of bioterrorism including anthrax, botulism, and smallpox. She has over 19 years of experience leading a variety of public health investigations and outbreaks (e.g., fungal endophthalmitis, hepatitis A, non-tuberculous mycobacteria, Legionellosis, aspergillosis, medical-device and product contamination) and has worked with the Centers for Disease Control and Prevention (CDC) and CDPH investigating numerous outbreaks including those that are multijurisdictional.
During the COVID-19 pandemic, Dr. Kim served as the public health liaison to the Los Angeles CDC Quarantine Station, which included traveler monitoring and screening activities, following up on Do Not Board orders, overseeing outbreaks in the transportation sector (e.g., airlines, metro, transit), and planning/responding to maritime issues with the CDC. During the Ebola 2014–2016 outbreak in West Africa, she oversaw Ebola planning and response activities for suspected cases and traveler monitoring/screening activities for ACDC. She is board certified in infectious diseases and also received her masters of public health from the UCLA School of Public Health.
Lonnie King, Ph.D., is the Academy Professor and Dean Emeritus at The Ohio State University College of Veterinary Medicine. He previously was dean of the College of Veterinary Medicine at Ohio State, dean of the College of Veterinary Medicine at Michigan State University, and interim dean and
university vice-president for agriculture at the College of Food, Agriculture and Environmental Sciences at Ohio State. Dr. King served as the director of the National Center of Zoonotic, Vector-Borne, and Enteric Diseases with the Centers for Disease Control and Prevention (CDC) from 2006–2009, and was the administrator for the Animal and Plant Health Inspection Service at the U.S. Department of Agriculture, where he also served as the deputy administrator for veterinary services and the chief veterinary officer for the United States. His expertise focuses on emerging infectious diseases and zoo-noses, food safety, global health, public health, and One Health. Dr. King has been active in antimicrobial resistance issues and has worked at the interface of human and animal diseases. He is a member of the American Veterinary Medical Association and is a member of the National Academy of Medicine, where he served as vice chair of the Forum on Microbial Threats for almost 10 years. He has been honored with global awards in One Health, and Meritorious Service via the World Organization for Animal Health. He currently is serving for a sixth year as co-chair for the PACCARB (President’s Advisory Council to Combat Antibiotic Resistant Bacteria).
Marcelle Layton, M.D., is the assistant commissioner for the Bureau of Communicable Disease at the New York City (NYC) Department of Health and Mental Hygiene. As of December 1, 2021, she is the chief medical officer for the Council of State and Territorial Epidemiologists (CSTE). Dr. Layton has participated as a member of the National Academies’ Forum on Microbial Threats; the University of Pittsburgh’s Center for Civilian Biosecurity; the Executive Session on Domestic Preparedness of the John F. Kennedy School of Government, Harvard University; the IOM Committee on Effectiveness of National Biosurveillance Systems: Biowatch and the Public Health System; the H1N1 Subcommittee to the President’s Council of Advisors on Science and Technology; the Centers for Disease Control and Prevention’s Board of Scientific Counselors (from 2008 to 2011); and the National Institutes of Health’s National Science Advisory Board for Biosecurity. She was previously on the Executive Board of the CSTE from 2013 to 2020.
Dr. Layton played a key role in NYC’s public health response to the appearance of West Nile virus in 1999 and the attacks on the World Trade Center and intentional anthrax release in 2001, and has led the surveillance response to multiple emergencies in recent years including the 2009 H1N1 pandemic, the threat of imported Ebola and Zika virus, and the current COVID-19 pandemic.
Stephen Ostroff, Ph.D., served as the deputy commissioner for foods and veterinary medicine at the U.S. Food and Drug Administration (FDA) until early 2019. In addition to that position, he also served as the FDA’s chief
scientist and acting commissioner on two occasions. Before joining the FDA, Dr. Ostroff worked at the Centers for Disease Control and Prevention (CDC) from 1986–2005, serving as deputy director of the National Center for Infectious Diseases (NCID) and NCID associate director for epidemiologic science. He attained the rank of Assistant Surgeon General in the U.S. Public Health Service Commissioned Corps. Between leaving the CDC and joining the FDA, Dr. Ostroff led the Bureau of Epidemiology and served as acting physician general at the Pennsylvania Department of Health in Harrisburg.
Dr. Ostroff served as a member of the Healthy to Sail panel, which advised the Royal Caribbean and Norwegian cruise lines on the development and implementation of COVID-19 health and safety protocols between June 2020 and April 2021. He continued to serve as a compensated consultant to Norwegian through October 2021, including providing declaratory statements in July–August 2021 in litigation between Norwegian cruise lines and the State of Florida regarding the importance of verifying COVID-19 vaccination status.
He is a medical editor of the CDC’s Health Information for International Travel (the Yellow Book). Dr. Ostroff received his medical degree from the University of Pennsylvania School of Medicine and did residency training in internal medicine at the University of Colorado Health Sciences Center and in preventive medicine at the CDC. He holds adjunct faculty appointments at the Penn State College of Medicine and the University of Pittsburgh Graduate School of Public Health.
Edward T. Ryan, M.D., is a physician, scientist, educator, and public health advocate. Dr. Ryan received his undergraduate degree from Princeton University and his doctorate in medicine from Harvard University. He performed his graduate medical training at Massachusetts General Hospital in Boston. Dr. Ryan is a professor of immunology and infectious diseases at the Harvard T. H. Chan School of Public Health, professor of medicine at Harvard Medical School, and director of global infectious diseases at Massachusetts General Hospital. Dr. Ryan’s efforts focus on mitigating the burden and impact of global infectious diseases. Dr. Ryan is a National Institutes of Health (NIH) MERIT Awardee. Dr. Ryan’s scholarly efforts include over 240 peer-reviewed publications, and 90 editorials, chapters, and reviews. He also serves in a number of editorial capacities and has served on expert and advisory committees and working groups for the World Health Organization (WHO), the Institute of Medicine/National Academy of Sciences, the Centers for Disease Control and Prevention, the NIH, the Wellcome Trust, and PATH (formerly the Program for Appropriate Technologies in Health). Dr. Ryan is a previous president of the American Society of Tropical Medicine & Hygiene (ASTMH), and is a fellow of the
American College of Physicians, the Infectious Diseases Society of America, the ASTMH, and the American Academy of Microbiology.
Alessandro Vespignani is the director of the Network Science Institute and Sternberg Family Distinguished University Professor with interdisciplinary appointments in the College of Computer and Information Science, College of Science, and the Bouvé College of Health Sciences at Northeastern University. Before joining Northeastern University, Mr. Vespignani was J. H. Rudy Professor of Informatics and Computing at Indiana University, serving as the director of the Center for Complex Networks and Systems Research and the associate director of the Pervasive Technology Institute. His research interests include complex systems and networks, and the data-driven computational modeling of epidemics. Mr. Vespignani’s recent work has focused on modeling the spatial spread of epidemics, including the realistic and data-driven modeling of emerging infectious diseases. He is a fellow of the American Physical Society and the Network Science Society. He has been inducted into the Academia Europaea (section Physics and Engineering), and received the Doctorate Honoris Causa from Delft University of Technology in the Netherlands and the John Graunt award for extraordinary achievements in one of the population sciences.
C. Jason Wang, M.D., Ph.D., is director of the Center for Policy, Outcomes, and Prevention and co-chair of the mobile health group in the Center for Population Health Sciences at Stanford University. He is a professor of pediatrics and health policy at Stanford University. He received his B.S. from MIT, M.D. from Harvard Medical School, and Ph.D. in policy analysis from RAND. After pediatric residency training at the University of California, San Francisco, he worked in Greater China with McKinsey and Company. In 2000, he served as the project manager for Taiwan’s Healthcare Reform Taskforce. He is currently on the RAND Health Board. Dr. Wang has conducted an independent evaluation on Taiwan’s COVID-19 response and has published extensively on both Taiwan’s experience as well as other ways to improve the detection, containment, and mitigation of COVID-19.
Among his honors, he was selected as the student speaker for the Harvard Medical School commencement ceremony in 1996, is a recipient of the 2011 National Institutes of Health Director’s New Innovator Award, and was an invited speaker for the Johns Hopkins Bloomberg School of Public Health’s 100th Year, Child Health Policy Symposium.
Rueben Warren, Ph.D., M.P.H., DrPh, is professor of bioethics and director of the National Center for Bioethics in Research and Health Care at Tuskegee University. He has served as dean of the School of Dentistry at Meharry Medical College (MMC) (1983–1988); associate director for
minority health at the Centers for Disease Control and Prevention (1988–1997); associate director for urban affairs at the Agency for Toxic Substances and Disease Registry (1997–2004); and director of infrastructure development at the National Institute for Minority Health and Health Disparities (part-time, 2004–2007). His professional and research interests include health services research, minority health, public health, ethics and theology, environmental justice, and international health. In 1999, Dr. Warren received the Distinguished Harvard Alumni Award. From MMC he has received an honorary degree of Doctor of Medical Science (1999), the President’s Distinguished Service Award (2001), a School of Dentistry Dean Emeritus (2003) appointment, and an honorary Doctor of Humane Letters (2013). From the NYU School of Dentistry, he received the Michael C. Alfano Award for Promoting Diversity (2010). He earned a BA in biology at San Francisco State University; a doctor of dental surgery at MMC; an MPH, DrPH, and teaching fellowship at Harvard School of Public Health; residency in dental public health at the Harvard School of Dental Medicine (board certified in dental public health); a masters of divinity at the Interdenominational Theological Center; and a certificate in bioethics at Georgetown University.
Liz Ashby is an associate program officer with the Board on Global Health, where she supports the Forum on Microbial Threats. Her previous work with the National Academies includes writing, research, and program support for the studies Globally Resilient Supply Chains for Pandemic and Seasonal Influenza Vaccines and Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response: Lessons from COVID-19. Previously, she conducted research in collaboration with the PREDICT project for global disease surveillance to assess risk factors for zoonotic disease transmission in Kenya. She also worked with a private consulting company to apply social marketing interventions and innovative technologies to pressing global health issues. Her primary interests include applying a One Health lens to analyze challenges related to emerging pandemic threats. She has an M.S. in environmental science from George Mason University, where she studied the intersection of human, animal, and environmental health.
Elizabeth Ferré, M.P.H., is a research associate with the Board on Global Health in the Health and Medicine Division at the National Academies of Sciences, Engineering, and Medicine in Washington, DC. She is currently working on the Analysis to Enhance the Effectiveness of the Federal Quarantine Station Network Based on Lessons from the COVID-19 Pandemic
project. Previously, she has worked on sustainable financing methods for global health security and preparedness for the Global Health Security Agenda Consortium through Gryphon Scientific. Her interests lie in anticipation, prevention, detection, and response to infectious diseases, global health security, pandemic preparedness, and achievement of health equity. She is originally from Boston, Massachusetts, and attended James Madison University for a bachelor’s of science in public health and then completed a master’s of public health with a concentration in global health from the University of Maryland School of Medicine.
Rose Marie Martinez, Sc.D., has been the Director of the Health and Medicine Division’s (formerly the Institute of Medicine’s) Board on Population Health and Public Health Practice since 1999. Prior to joining the Academies, Dr. Martinez was a senior health researcher at Mathematica Policy Research (1995–1999) where she conducted research on the impact of health system change on the public health infrastructure, access to care for vulnerable populations, managed care, and the health care workforce. She is a former assistant director for health financing and policy with the U.S. General Accounting Office and served for 6 years directing research studies for the Regional Health Ministry of Madrid, Spain.
Julie A. Pavlin, M.D., Ph.D., M.P.H., is the director of the Board on Global Health and is board certified in preventive medicine and public health. She is a retired Colonel in the U.S. Army with previous assignments including the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand; the Walter Reed Army Institute of Research; and the U.S. Army Medical Research Institute for Infectious Diseases. After she retired from active duty, she served as the deputy director at the Armed Forces Health Surveillance Center. She concentrated most of her time with the Department of Defense in the design of real-time disease surveillance systems and was a cofounder of the International Society for Disease Surveillance.
Emilie Ryan-Castillo is a research assistant with the Board on Global Health. She has a B.S. in public health from American University. In the past, she was a program assistant at FHI 360 and worked on diabetes prevention and childhood obesity research projects. In this role, she helped execute several large meetings bringing together the top researchers from the Centers for Disease Control and Prevention, the National Institutes of Health, the U.S. Department of Agriculture, and the Robert Wood Johnson Foundation for the National Collaborative on Childhood Obesity Research. She recently served as a rural community health volunteer in Peace Corps Benin, where she worked on improving maternal health, vaccination rates, and community outreach at a local clinic in the Borgou Department.
Tequam Worku, M.P.H., is a program officer for the Board on Global Health at the National Academies of Sciences, Engineering, and Medicine. She previously worked at the Association of State and Territorial Health Officials as a senior analyst for Clinical to Community Connections, managing federally funded projects on community health workers and ending the HIV epidemic. Her past experience also includes working on federally funded projects related to chronic diseases and the development of healthy communities, including the promotion of healthy aging and hypertension prevention and control (the Million Hearts Initiative). Tequam has worked on various research projects on topics including breast cancer disparities and cultural competency in health care. Additionally, she has worked internationally supporting data analysis and knowledge management efforts. She is committed to efforts aimed at bridging disparities in health and has been actively involved in health-equity initiatives. She earned her B.A. in biology from University of Maryland Baltimore County and an M.P.H. from The George Washington University and is currently pursuing a DrPH at Morgan State University.